← Eichor
Study identifier: NCT07409337 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms

Condition: Primary Dysmenorrhea · Premenstrual Syndrome · Menstrual Pain  ·  Sponsor: Nigde Omer Halisdemir University

PhaseNA
Planned participants120
Who can joinFemale, 18 Years to 30 Years
Healthy volunteersYes

About this study

This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.

This description comes directly from the study's public registry record.

Talk to the study team

Pınar Erdoğan, Assoc. Prof.  ·  +905233646954  ·  drpinarerdogan@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Niğde Ömer Halisdemir University HospitalNiğde, Merkez, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07409337